RECURSION PHARMACEUTICALS, INC. (RXRX) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading RXRX…

RECURSION PHARMACEUTICALS, INC. (RXRX) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

RECURSION PHARMACEUTICALS, INC.

RXRX · CIK 1601830

4 · Oct 2, 2026 · Director Li Dean Y was granted 3,378 Class A Common Stock

4

Director Li Dean Y was granted 3,378 Class A Common Stock

Filed: Oct 2, 2026
Period: Oct 1, 2026
Accession: 0001601830-26-000115
Filer: RECURSION PHARMACEUTICALS, INC.

View on SEC.gov All SEC filings

Filing document

FORM 4

xslF345X06/wk-form4_1790979423.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4FORM 4wk-form4_1790979423.xml
Open SEC.gov